#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

MicroRNA-155 Promotes Autophagy to Eliminate Intracellular Mycobacteria by Targeting Rheb


Mycobacterium tuberculosis is a hard-to-eradicate intracellular pathogen that infects one-third of the global population. It can live within macrophages owning to its ability to arrest phagolysosome biogenesis. Autophagy has recently been identified as an effective way to control the intracellular mycobacteria by enhancing phagosome maturation. In the present study, we demonstrate a novel role of miR-155 in regulating the autophagy-mediated anti-mycobacterial response. Both in vivo and in vitro studies showed that miR-155 expression was significantly enhanced after mycobacterial infection. Forced expression of miR-155 accelerated the autophagic response in macrophages, thus promoting the maturation of mycobacterial phagosomes and decreasing the survival rate of intracellular mycobacteria, while transfection with miR-155 inhibitor increased mycobacterial survival. However, macrophage-mediated mycobacterial phagocytosis was not affected after miR-155 overexpression or inhibition. Furthermore, blocking autophagy with specific inhibitor 3-methyladenine or silencing of autophagy related gene 7 (Atg7) reduced the ability of miR-155 to promote autophagy and mycobacterial elimination. More importantly, our study demonstrated that miR-155 bound to the 3′-untranslated region of Ras homologue enriched in brain (Rheb), a negative regulator of autophagy, accelerated the process of autophagy and sequential killing of intracellular mycobacteria by suppressing Rheb expression. Our results reveal a novel role of miR-155 in regulating autophagy-mediated mycobacterial elimination by targeting Rheb, and provide potential targets for clinical treatment.


Vyšlo v časopise: MicroRNA-155 Promotes Autophagy to Eliminate Intracellular Mycobacteria by Targeting Rheb. PLoS Pathog 9(10): e32767. doi:10.1371/journal.ppat.1003697
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003697

Souhrn

Mycobacterium tuberculosis is a hard-to-eradicate intracellular pathogen that infects one-third of the global population. It can live within macrophages owning to its ability to arrest phagolysosome biogenesis. Autophagy has recently been identified as an effective way to control the intracellular mycobacteria by enhancing phagosome maturation. In the present study, we demonstrate a novel role of miR-155 in regulating the autophagy-mediated anti-mycobacterial response. Both in vivo and in vitro studies showed that miR-155 expression was significantly enhanced after mycobacterial infection. Forced expression of miR-155 accelerated the autophagic response in macrophages, thus promoting the maturation of mycobacterial phagosomes and decreasing the survival rate of intracellular mycobacteria, while transfection with miR-155 inhibitor increased mycobacterial survival. However, macrophage-mediated mycobacterial phagocytosis was not affected after miR-155 overexpression or inhibition. Furthermore, blocking autophagy with specific inhibitor 3-methyladenine or silencing of autophagy related gene 7 (Atg7) reduced the ability of miR-155 to promote autophagy and mycobacterial elimination. More importantly, our study demonstrated that miR-155 bound to the 3′-untranslated region of Ras homologue enriched in brain (Rheb), a negative regulator of autophagy, accelerated the process of autophagy and sequential killing of intracellular mycobacteria by suppressing Rheb expression. Our results reveal a novel role of miR-155 in regulating autophagy-mediated mycobacterial elimination by targeting Rheb, and provide potential targets for clinical treatment.


Zdroje

1. RussellDG, BarryCE (2010) Tuberculosis: what we don't know can, and does, hurt us. Science 328: 852–856.

2. KorbelDS, SchneiderBE, SchaibleUE (2008) Innate immunity in tuberculosis: myths and truth. Microbes Infect 10: 995–1004.

3. QuesniauxV, FremondC, JacobsM, ParidaS, NicolleD, et al. (2004) Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect 6: 946–959.

4. Hernandez-PandoR, OrozcoH, AguilarD (2009) Factors that deregulate the protective immune response in tuberculosis. Arch Immunol Ther Exp (Warsz) 57: 355–367.

5. BhattK, SalgameP (2007) Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol 27: 347–362.

6. BaenaA, PorcelliSA (2009) Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens 74: 189–204.

7. GutierrezMG, MasterSS, SinghSB, TaylorGA, ColomboMI, et al. (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119: 753–766.

8. DereticV, SinghS, MasterS, HarrisJ, RobertsE, et al. (2006) Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell Microbiol 8: 719–727.

9. LevineB, KroemerG (2008) Autophagy in the pathogenesis of disease. Cell 132: 27–42.

10. MizushimaN, LevineB, CuervoAM, KlionskyDJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451: 1069–1075.

11. LevineB, KlionskyDJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6: 463–477.

12. DelgadoM, SinghS, De HaroS, MasterS, PonpuakM, et al. (2009) Autophagy and pattern recognition receptors in innate immunity. Immunol Rev 227: 189–202.

13. OgawaM, YoshimoriT, SuzukiT, SagaraH, MizushimaN, et al. (2005) Escape of intracellular Shigella from autophagy. Science 307: 727–731.

14. BirminghamCL, SmithAC, BakowskiMA, YoshimoriT, BrumellJH (2006) Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol Chem 281: 11374–11383.

15. RichKA, BurkettC, WebsterP (2003) Cytoplasmic bacteria can be targets for autophagy. Cell Microbiol 5: 455–468.

16. LevineB, MizushimaN, VirginHW (2011) Autophagy in immunity and inflammation. Nature 469: 323–335.

17. SanjuanMA, MilastaS, GreenDR (2009) Toll-like receptor signaling in the lysosomal pathways. Immunol Rev 227: 203–220.

18. DereticV (2010) Autophagy in infection. Curr Opin Cell Biol 22: 252–262.

19. LevineB, YuanJ (2005) Autophagy in cell death: an innocent convict? J Clin Invest 115: 2679–2688.

20. FuLL, WenX, BaoJK, LiuB (2012) MicroRNA-modulated autophagic signaling networks in cancer. Int J Biochem Cell Biol 44: 733–736.

21. TaganovKD, BoldinMP, BaltimoreD (2007) MicroRNAs and immunity: tiny players in a big field. Immunity 26: 133–137.

22. RajaramMV, NiB, MorrisJD, BrooksMN, CarlsonTK, et al. (2011) Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b. Proc Natl Acad Sci U S A 108: 17408–17413.

23. LiuY, WangX, JiangJ, CaoZ, YangB, et al. (2011) Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. Mol Immunol 48: 1084–1090.

24. MaF, XuS, LiuX, ZhangQ, XuX, et al. (2011) The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol 12: 861–869.

25. TopEM, WilsonDB (2011) Special issue of Current Opinion in Microbiology, focused on ‘Ecology and Industrial Microbiology’. Curr Opin Microbiol 14: 227–228.

26. O'ConnellRM, TaganovKD, BoldinMP, ChengG, BaltimoreD (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104: 1604–1609.

27. CeppiM, PereiraPM, Dunand-SauthierI, BarrasE, ReithW, et al. (2009) MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci U S A 106: 2735–2740.

28. EisPS, TamW, SunL, ChadburnA, LiZ, et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102: 3627–3632.

29. HaaschD, ChenYW, ReillyRM, ChiouXG, KoterskiS, et al. (2002) T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol 217: 78–86.

30. XiaoB, LiuZ, LiBS, TangB, LiW, et al. (2009) Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 200: 916–925.

31. GhorpadeDS, LeylandR, Kurowska-StolarskaM, PatilSA, BalajiKN (2012) MicroRNA-155 is required for M. bovis BCG mediated apoptosis of macrophages. Mol Cell Biol 32: 2239–2253.

32. WuJ, LuC, DiaoN, ZhangS, WangS, et al. (2012) Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study. Hum Immunol 73: 31–37.

33. FaraoniI, AntonettiFR, CardoneJ, BonmassarE (2009) miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792: 497–505.

34. RodriguezA, VigoritoE, ClareS, WarrenMV, CouttetP, et al. (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316: 608–611.

35. O'ConnellRM, KahnD, GibsonWS, RoundJL, ScholzRL, et al. (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33: 607–619.

36. SuzukiHI, AraseM, MatsuyamaH, ChoiYL, UenoT, et al. (2011) MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol Cell 44: 424–436.

37. ArranzA, DoxakiC, VergadiE, Martinez de la TorreY, VaporidiK, et al. (2012) Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A 109: 9517–9522.

38. LiuPT, ModlinRL (2008) Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol 20: 371–376.

39. BermudezLE, YoungLS (1988) Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 140: 3006–3013.

40. FlynnJL, GoldsteinMM, ChanJ, TrieboldKJ, PfefferK, et al. (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561–572.

41. FratazziC, ArbeitRD, CariniC, RemoldHG (1997) Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J Immunol 158: 4320–4327.

42. LeeJ, RemoldHG, IeongMH, KornfeldH (2006) Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J Immunol 176: 4267–4274.

43. LevineB, DereticV (2007) Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 7: 767–777.

44. HerbstS, SchaibleUE, SchneiderBE (2011) Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS One 6: e19105.

45. JagannathC, LindseyDR, DhandayuthapaniS, XuY, HunterRLJr, et al. (2009) Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 15: 267–276.

46. KimJJ, LeeHM, ShinDM, KimW, YukJM, et al. (2012) Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action. Cell Host Microbe 11: 457–468.

47. Thoma-UszynskiS, StengerS, TakeuchiO, OchoaMT, EngeleM, et al. (2001) Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291: 1544–1547.

48. Vila-del SolV, Diaz-MunozMD, FresnoM (2007) Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages. J Leukoc Biol 81: 272–283.

49. DharmarajaAT, AlvalaM, SriramD, YogeeswariP, ChakrapaniH (2012) Design, synthesis and evaluation of small molecule reactive oxygen species generators as selective Mycobacterium tuberculosis inhibitors. Chem Commun (Camb) 48: 10325–10327.

50. WangP, HouJ, LinL, WangC, LiuX, et al. (2010) Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol 185: 6226–6233.

51. VigoritoE, PerksKL, Abreu-GoodgerC, BuntingS, XiangZ, et al. (2007) microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27: 847–859.

52. O'ConnellRM, RaoDS, ChaudhuriAA, BoldinMP, TaganovKD, et al. (2008) Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 205: 585–594.

53. O'ConnellRM, ChaudhuriAA, RaoDS, BaltimoreD (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A 106: 7113–7118.

54. TangB, XiaoB, LiuZ, LiN, ZhuED, et al. (2010) Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation. FEBS Lett 584: 1481–1486.

55. HuangX, ShenY, LiuM, BiC, JiangC, et al. (2012) Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma. Am J Pathol 181: 26–33.

56. SunYM, LinKY, ChenYQ (2013) Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol 6: 6.

57. ZhaoA, ZengQ, XieX, ZhouJ, YueW, et al. (2012) MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression. J Genet Genomics 39: 29–35.

58. ZengCW, ZhangXJ, LinKY, YeH, FengSY, et al. (2012) Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways. Mol Pharmacol 81: 578–586.

59. GaramiA, ZwartkruisFJ, NobukuniT, JoaquinM, RoccioM, et al. (2003) Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11: 1457–1466.

60. BoseSK, ShrivastavaS, MeyerK, RayRB, RayR (2012) Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance. J Virol 86: 6315–6322.

61. SeoG, KimSK, ByunYJ, OhE, JeongSW, et al. (2011) Hydrogen peroxide induces Beclin 1-independent autophagic cell death by suppressing the mTOR pathway via promoting the ubiquitination and degradation of Rheb in GSH-depleted RAW 264.7 cells. Free Radic Res 45: 389–399.

62. TattoliI, SorbaraMT, VuckovicD, LingA, SoaresF, et al. (2012) Amino acid starvation induced by invasive bacterial pathogens triggers an innate host defense program. Cell Host Microbe 11: 563–575.

63. LiaoXH, MajithiaA, HuangX, KimmelAR (2008) Growth control via TOR kinase signaling, an intracellular sensor of amino acid and energy availability, with crosstalk potential to proline metabolism. Amino Acids 35: 761–770.

64. TanidaI, YamajiT, UenoT, IshiuraS, KominamiE, et al. (2008) Consideration about negative controls for LC3 and expression vectors for four colored fluorescent protein-LC3 negative controls. Autophagy 4: 131–134.

65. MariencheckWI, SavovJ, DongQ, TinoMJ, WrightJR (1999) Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa. Am J Physiol 277: L777–786.

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2013 Číslo 10
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#